INTERCEPT PHARMACEUTICALS IN

CUSIP: 45845PAB4 Class: CONV BD US

PenderFund Capital Management Ltd.'s Holding History (CIK: 0001706164)

Note: Option positions (PUT/CALL) are excluded.

Q3 2023
Shares 9,295,000 Value ($000) $13 Avg Close — Range —
Q2 2023
Shares 11,795,000 Value ($000) $13 Avg Close — Range —
Q1 2023
Shares 11,795,000 Value ($000) $13 Avg Close — Range —
Q4 2022
Shares 11,795,000 Value ($000) $12 Avg Close — Range —
Q3 2022
Shares 11,795,000 Value ($000) $12,434 Avg Close — Range —
Q2 2022
Shares 11,795,000 Value ($000) $10,081 Avg Close — Range —
Q2 2021
Shares 6,500,000 Value ($000) $5,424 Avg Close — Range —
Q1 2021
Shares 6,500,000 Value ($000) $5,420 Avg Close — Range —
Q4 2020
Shares 5,000,000 Value ($000) $3,839 Avg Close — Range —
Q3 2020
Shares 5,000,000 Value ($000) $4,719 Avg Close — Range —